Gender and addiction and other mental disorders comorbidity: sociodemographic, clinical, and treatment differences

Arch Womens Ment Health. 2023 Oct;26(5):639-650. doi: 10.1007/s00737-023-01353-w. Epub 2023 Aug 4.

Abstract

The co-occurrence of substance use disorders (SUD) and other mental disorders (OMD) is assumed to be high, but the details are uncertain in Spain. The objective of the present study was to know the prevalence of this comorbidity, as well as the pharmacological treatment, both in specific addiction treatment networks and in mental health networks, with a gender perspective. Observational, multicenter study, with a randomized sample, of patients under treatment for SUD or OMD in Spain (N = 1783). A specific questionnaire, collecting sociodemographic and clinical variables, diagnosed SUD and OMD, and prescribed psychotropic drugs, was completed by treating clinicians. Differences between females and males were searched. A high prevalence of OMD was found in those patients treated for their SUD (71%), and also of diagnoses of SUD (59%) in people treated for OMD. Significant relationships between addiction to certain substances and specific mental disorders were found (with no main differences between women and men). The treatments for OMD were very common in the addiction treatment networks, but that of SUDs in those patients treated in the mental health networks was less than expected. A high prescription of benzodiazepines was found. Women were less frequently diagnosed with cannabis, opioid, and especially cocaine use disorders, and they had fewer psychotic disorders and more affective, anxiety, sleep, and eating disorders, with the rest being the same, including personality disorders. Women had fewer treatments with agonists and more with antagonists, and more prescriptions of anxiolytics and antidepressants. This study provides preliminary information on the coexistence in routine clinical practice of addictive disorders and other mental disorders in Spain, and on the treatment provided, and shows differences in prevalence and clinical characteristics, and especially in treatment approaches between women and men. Thus, should be useful to adapt the treatment response with greater precision, and with a gender perspective.

Keywords: Comorbidity; Gender; Mental disorder; Prevalence; Substance use disorder; Treatment.

Publication types

  • Randomized Controlled Trial
  • Multicenter Study

MeSH terms

  • Comorbidity
  • Female
  • Humans
  • Male
  • Mental Disorders* / psychology
  • Personality Disorders / epidemiology
  • Psychotic Disorders* / epidemiology
  • Substance-Related Disorders* / epidemiology
  • Substance-Related Disorders* / psychology